232 related articles for article (PubMed ID: 11605176)
1. European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer.
Novello S; Le Chevalier T
Semin Oncol; 2001 Aug; 28(4 Suppl 14):3-9. PubMed ID: 11605176
[TBL] [Abstract][Full Text] [Related]
2. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
Bunn PA
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
Belani CP
Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
Bonomi P; Faber LP; Recine D; Lincoln S
Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927
[TBL] [Abstract][Full Text] [Related]
5. Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.
Choy H; Akerley W; DeVore RF
Semin Oncol; 1999 Feb; 26(1 Suppl 2):36-43. PubMed ID: 10190782
[TBL] [Abstract][Full Text] [Related]
6. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
[TBL] [Abstract][Full Text] [Related]
7. High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.
Socinski MA; Shea TC
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-45-S12-51. PubMed ID: 9331121
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
9. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Bunn PA
Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Aisner J; Belani CP; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin MJ
Semin Oncol; 1995 Oct; 22(5 Suppl 12):17-21. PubMed ID: 7481856
[TBL] [Abstract][Full Text] [Related]
11. One-hour paclitaxel in the treatment of non-small cell lung cancer.
Hainsworth JD; Greco FA
Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
[TBL] [Abstract][Full Text] [Related]
12. Combination paclitaxel and platinum in the treatment of lung cancer: US experience.
Bunn PA
Semin Oncol; 1996 Dec; 23(6 Suppl 15):9-15. PubMed ID: 8996590
[TBL] [Abstract][Full Text] [Related]
13. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
Socinski MA; Clark JA; Halle J; Steagall A; Kaluzny B; Rosenman JG
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer.
Splinter TA
Semin Oncol; 1996 Dec; 23(6 Suppl 16):59-61. PubMed ID: 9007124
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
[TBL] [Abstract][Full Text] [Related]
17. Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer.
Rosell R; Felip E
Semin Oncol; 2001 Aug; 28(4 Suppl 14):37-44. PubMed ID: 11605182
[TBL] [Abstract][Full Text] [Related]
18. Platinum drugs in the treatment of non-small-cell lung cancer.
Cosaert J; Quoix E
Br J Cancer; 2002 Oct; 87(8):825-33. PubMed ID: 12373594
[TBL] [Abstract][Full Text] [Related]
19. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
Hainsworth JD; Greco FA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785
[TBL] [Abstract][Full Text] [Related]
20. Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.
Choy H; DeVore RF; Hande KR; Porter LL; Rosenblatt P; Yunus F; Schlabach L; Smith C; Shyr Y; LaPorte K; Johnson DH
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-21-S12-26. PubMed ID: 9331115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
